A young women with secondary amenorrhea and galactorrhea. MRI shows a tumour of < lOmm diameter in the pituitary fossa. Treatment is:

Okay, let's tackle this question. The patient is a young woman with secondary amenorrhea and galactorrhea. The MRI shows a pituitary tumor less than 10mm. So, the main issue here is to figure out the correct treatment.

First, the core concept. Secondary amenorrhea means no menstrual periods for three months or more in someone who had regular cycles. Galactorrhea is milk discharge not related to breastfeeding. These symptoms are classic for hyperprolactinemia. The pituitary tumor in this case is likely a prolactinoma, which is a benign tumor that secretes prolactin. The MRI finding of a tumor under 10mm classifies it as a microadenoma.

Now, the treatment options. The standard approach for a prolactinoma is dopamine agonists like cabergoline or bromocriptine. These drugs reduce prolactin levels and shrink the tumor. Surgical intervention is usually reserved for large tumors or those causing significant symptoms. Since this is a microadenoma, medical management is first-line.

Looking at the options, the correct answer should be a dopamine agonist. Let's assume the options given include cabergoline (Option C) as a common choice. The other options might be incorrect treatments. For example, Option A could be a GnRH agonist, which is used for other conditions like endometriosis. Option B might be a dopamine antagonist like risperidone, which would increase prolactin. Option D could be a corticosteroid, which isn't indicated here.

Clinical pearls: Remember that prolactinomas are the most common cause of hyperprolactinemia. Dopamine agonists are the first-line treatment. Also, microadenomas are typically managed medically, while macroadenomas may require surgery if they're causing visual field deficits or mass effect.

**Core Concept**
The clinical scenario describes **hyperprolactinemia** secondary to a **pituitary microadenoma**, a benign tumor <10 mm in diameter. Prolactinomas are the most common functional pituitary tumors, causing **amenorrhea-galactorrhea syndrome** due to elevated prolactin suppressing GnRH and gonadotropin secretion. **Why the Correct Answer is Right** Dopamine agonists like **cabergoline** or **bromocriptine** are first-line treatments for prolactinomas. They inhibit prolactin secretion via **D2 dopamine receptors** on lactotrophs and reduce tumor size. Cabergoline is preferred due to longer half-life and fewer side effects compared to bromocriptine. Medical therapy normalizes menstrual cycles, reduces galactorrhea, and prevents complications like osteoporosis. **Why Each Wrong Option is Incorrect** **Option A:** GnRH agonists (e.g., leuprolide) are used for endometriosis or prostate cancer, not hyperprolactinemia. **Option B:** Dopamine antagonists (e.g., risperidone) increase prolactin levels, exacerbating the condition. **Option D:** Corticosteroids are used for pituitary apoplexy or Cushing’s disease, not prolactinomas. **Clinical Pearl / High-Yield Fact** **Prolactinomas are

✓ Correct Answer: D. Bromocriptine